Numerous proposed hypotheses explain how APOE isoform-specific differences might increase the risk of AD, ranging from neurotoxic effect based on domain interaction, binding to, deposition and clearance of Aβ, differential lipidation of isoforms, and neurotoxic and neuroprotection effects. The gene discussed is APOE; the disease is Alzheimer disease.